[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 384
Citations 0
Comment & Response
November 5, 2014

Cardiac Assessment Before Stem Cell Transplantation for Systemic Sclerosis—Reply

Author Affiliations
  • 1Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht, the Netherlands
  • 2Assistance Publique-Hôpitaux de Paris, Saint-Louis Hospital, Paris, France
  • 3Department of Rheumatology, University Hospital Basel, Basel, Switzerland
JAMA. 2014;312(17):1803-1804. doi:10.1001/jama.2014.12572

In Reply Dr Burt and colleagues emphasize the importance of extensive cardiopulmonary screening before undertaking autologous hematopoietic stem cell transplantation in patients with severe systemic sclerosis. When the ASTIS trial was launched in 2001, phase 1/2 data indicated that patients with systemic sclerosis and a mean pulmonary arterial pressure greater than 50 mm Hg measured by right heart catheterization had an unacceptable risk of treatment-related mortality1 and were therefore excluded from the ASTIS trial.

First Page Preview View Large
First page PDF preview
First page PDF preview